Investment Summary |
|
|---|---|
| Date | 2021-08-03 |
| Target | MAIT |
| Sector | Information Technology |
| Investor(s) | 3i Private Equity |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1945 |
| PE ASSETS | 21.0B GBP |
| Size | Mega |
| Type | Sector Agnostic |
3i Private Equity is the private equity arm of 3i Group, a publicly held, global investment firm focused on private equity and infrastructure investing. 3i Private Equity generally targets buyout and growth capital financings and looks for opportunities across Europe, North America, and Asia. The Firm's targeted transaction range is €100 to €500 million. Industries of interest include business services, healthcare, consumer, media, oil/gas & power, technology, and financial services. 3i Group was originally formed in 1945 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 240 of 251 |
| Sector: Information Technology M&A | 8 of 9 |
| Type: Growth Capital M&A Deals | 46 of 52 |
| Country: Germany M&A | 17 of 18 |
| Year: 2021 M&A | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-19 |
WilsonHCG
Tampa, Florida, United States WilsonHCG is a provider of talent management solutions. WilsonHCG offers recruitment process outsourcing and outsourced talent solutions to assist corporations with a broad range of talent acquisition needs. WilsonHCG was founded in 2002 and is based in Tampa, Florida. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-01 |
ten23 health
Basel, Switzerland ten23 health is a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (“CDMO”) focused on helping innovative biotech and pharma customers develop and commercialise injectable biopharmaceutical drugs. ten23 health is based in Basel, Switzerland. |
Buy | - |
